Skip to main content

Störungen der Bildung von Sexualsteroidhormonen und Hyperandrogenämie bei der Frau

Disorders of sex steroid hormone production and hyperandrogenemia in women

Zusammenfassung

Defekte der Steroidhormonsynthese können mit einem Mangel oder Überschuss an Androgenen einhergehen, die zu Störungen der Geschlechtsentwicklung und im weiblichen Geschlecht zur Ovarialinsuffizienz führen.

Abstract

Defects of steroid hormone biosynthesis can be associated with deficient or increased concentrations of androgens leading to disorders of sexual development or ovarian dysfunction.

This is a preview of subscription content, access via your institution.

Abb. 1

Literatur

  1. 1.

    Lin D, Sugawara T, Strauss JF et al (1995) Role os steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828–1831

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Rheaume E, Simard J, Morel Y et al (1992) Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxystroid dehydrogenase gene. Nat Genet 1:239–245

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Pang S, Lerner AJ, Stoner E et al (1985) Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab 60:428–439

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Chung BC, Picado-Leonard J, Haniu M et al (1987) Cytochrome P450C17 (steroid 17 hydroxylase/17,20-lyase): cloning of human adrenal and testis cDNAs indicate the same gene is expressed in both tissues. Proc Natl Acad Sci 84:407–411

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Geissler WMD, Davis DL, Wu L et al (1994) Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet 7:34–39

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Thipgen AE, Davis DL, Milatovich A et al (1992) Molecular genetics of 5α-reductase 2 deficiency. J Clin Invest 90:799–809

    Article  Google Scholar 

  7. 7.

    Evans CT, Ledesma DB, Schulz TZ et al (1986) Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P450mRNA. Proc Natl Acad Sci 83:6387–6391

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    White PC, Speiser PW (2000). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Clayton PE, Miller WL, Oberfield SE et al (2002). Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkens Pediatric Endocrine Society and the European Society For Pediatric Endocrinology. J Clin Endocrinol Metab 87:4048–4053

    Article  CAS  Google Scholar 

  10. 10.

    Blanché H, Vexiau P, Clauin S et al (1997) Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Mut 101:56–60

    Google Scholar 

  11. 11.

    New MI (2006) Nonclassical 21-hydroxylase deficiency. Clin Endocrinol Metab 91:4205–4214

    Article  CAS  Google Scholar 

  12. 12.

    Ezquieta B, Beneyto M, Muñoz-Pacheco R et al (2006) Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis. Prenat Diagn 26:1172–1178

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Chua S, Szabo P, Vitek A et al (1987) Cloning of cDNA encoding 11β-hydroxylase (P450C11). Proc Natl Acad Sci 84:7193–7197

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Wassif CA, Maslen C, Kachilele-Linjewile et al (1998) Mutations in the human sterol delta-7 reductase gene in 11q12–13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63:55–62

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Fluck CE, Tajima T, Pandey AV, Arlt W (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228–230

    PubMed  Article  Google Scholar 

  16. 16.

    Kahsar-Miller MD, Nixon C, Boots LR et al (2001) Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75:53–58

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Moller DE, Cohen O, Yamaguchi Y et al (1994) Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43:247–255

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Kadowaki T, Kadowaki H, Accili D, Taylor SI (1990) Substitution of lysine for asparagines at position in the alpha-subunit of the human insulin receptor: a mutation that impairs transport of receptors in the cell surface and decreases the affinity of insulin binding. J Biol Chem 265:19143–19150

    PubMed  CAS  Google Scholar 

  19. 19.

    OMIM, http://www.ncbi.nlm.nih.gov/omim/

  20. 20.

    Urbanek M (2007) The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 3:103–111

    PubMed  Article  CAS  Google Scholar 

Download references

Interessenkonflikt

Die Autoren geben an, dass kein Interessenkonflikt besteht.

Author information

Affiliations

Authors

Corresponding author

Correspondence to P. Wieacker.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wieacker, P., Preisler-Adams, S. Störungen der Bildung von Sexualsteroidhormonen und Hyperandrogenämie bei der Frau. medgen 23, 244–248 (2011). https://doi.org/10.1007/s11825-011-0276-x

Download citation

Schlüsselwörter

  • Gonadale Steroidhormonsynthese
  • Hyperandrogenämie
  • Syndrom polyzystischer Ovarien
  • Androgenisierung

Keywords

  • Gonadal steroid hormones
  • Hyperandrogenemia
  • Polycystic ovary syndrome
  • Androgenization